Cochlear Limited CHEOY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.58B | 1.55B | 1.51B | 1.51B | 1.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.58B | 1.55B | 1.51B | 1.51B | 1.52B |
| Cost of Revenue | 462.74M | 437.47M | 410.58M | 402.76M | 398.01M |
| Gross Profit | 1.11B | 1.11B | 1.10B | 1.10B | 1.12B |
| SG&A Expenses | 623.69M | 609.28M | 592.39M | 598.04M | 608.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -8.93M | -9.25M | -9.52M | -9.93M | -10.42M |
| Total Operating Expenses | 1.29B | 1.24B | 1.18B | 1.18B | 1.18B |
| Operating Income | 281.67M | 303.81M | 324.52M | 330.28M | 338.80M |
| Income Before Tax | 140.19M | 217.50M | 293.19M | 313.28M | 336.13M |
| Income Tax Expenses | 44.13M | 57.67M | 70.84M | 77.10M | 84.07M |
| Earnings from Continuing Operations | 96.07 | 159.83 | 222.35 | 236.18 | 252.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 96.07M | 159.83M | 222.35M | 236.18M | 252.06M |
| EBIT | 281.67M | 303.81M | 324.52M | 330.28M | 338.80M |
| EBITDA | 320.15M | 342.20M | 362.77M | 365.87M | 372.18M |
| EPS Basic | 1.47 | 2.44 | 3.40 | 3.61 | 3.85 |
| Normalized Basic EPS | 2.74 | 2.93 | 3.09 | 3.15 | 3.23 |
| EPS Diluted | 1.47 | 2.44 | 3.39 | 3.60 | 3.84 |
| Normalized Diluted EPS | 2.74 | 2.92 | 3.09 | 3.14 | 3.22 |
| Average Basic Shares Outstanding | 261.67M | 261.66M | 261.65M | 261.70M | 261.75M |
| Average Diluted Shares Outstanding | 261.91M | 262.08M | 262.26M | 262.34M | 262.42M |
| Dividend Per Share | 2.30 | 2.54 | 2.77 | 2.77 | 2.78 |
| Payout Ratio | 196.53% | 116.02% | 81.55% | 76.21% | 71.44% |